Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study

Journal of Hepatology

Volumn 59, Issue 5, 2013, Pages 949-956

  Manesis, Emanuel K ^a   Vourli, Georgia ^a   Dalekos, George ^b   Vasiliadis, Themistoclis ^c   Manolaki, Nina ^d   Hounta, Athina ^e   Koutsounas, Sotirios ^f   Vafiadis, Irini ^a   Nikolopoulou, Georgia ^g   Giannoulis, Gregory ^h   Germanidis, George ⁱ   Papatheodoridis, George ^a   Touloumi, Giota ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b University of Thessaly School of Medicine   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^f Hepatology Service   (Greece)

^g Greek National Center for Disease Control (KEELPNO)   (Greece)

^h TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

ⁱ General Hospital AXEA   (Greece)

Author keywords

Anti HDV testing in HBsAg positive patients; Chronic HDV infection; Greece; HDV clinical course; HDV epidemiology; Treatment of HDV

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; PEGINTERFERON ALPHA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; DELTA AGENT HEPATITIS; DISEASE COURSE; FEMALE; FOLLOW UP; GREECE; HUMAN; IMMIGRANT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PATHOGEN LOAD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; VIRUS LOAD;

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON (BOTH RECOMBINANT OR PEGYLATED DISTINGUISHED WHEN NECESSARY); ALT; ANTI-HDV TESTING IN HBSAG-POSITIVE PATIENTS; CHBE+; CHBE-; CHD; CHRONIC HDV INFECTION; CHRONIC HEPATITIS D; CI; CONFIDENCE INTERVAL; GREECE; HBEAG; HBEAG-NEGATIVE CHRONIC HEPATITIS B; HBEAG-POSITIVE CHRONIC HEPATITIS B; HBSAG; HBV; HBV DNA; HCC; HDV; HDV RNA; HDV-CLINICAL COURSE; HDV-EPIDEMIOLOGY; HDV-INFECTED PATIENTS WITH PERSISTENTLY NORMAL ALT; HDV-PNALT; HEPATITIS B " E" ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRAL DNA; HEPATITIS B VIRUS; HEPATITIS DELTA VIRAL RNA; HEPATITIS DELTA VIRUS; HEPATOCELLULAR CARCINOMA; HIV; HUMAN IMMUNODEFICIENCY VIRUS; IFN; ILLICIT INTRAVENOUS DRUG USE(R); INTERNATIONAL UNITS PER LITER; INTERNATIONAL UNITS PER MILLILITER; INTERQUARTILE RANGE; IQR; IU/L; IU/ML; IVDU; NA(S); NUCLEOS(T)IDE ANALOGUE(S); TREATMENT OF HDV;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COINFECTION; FEMALE; FOLLOW-UP STUDIES; GREECE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84885949262     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.07.005     Document Type: Article

References (29)

1. L.B. Polish, M. Gallagher, H.A. Fields, and Stephen C. Hadler Delta hepatitis: molecular biology and clinical and epidemiological features Clin Microbiol Rev 6 1993 211 229
2. S.J. Hadziyannis, A. Hatzakis, C. Papaioannou, C. Anastassakos, and E. Vassiliadis Endemic hepatitis delta virus infection in a Greek community Prog Clin Biol Res 234 1987 181 202
3. E. Sagnelli, T. Stroffolini, A. Ascione, M. Chiaramonte, A. Craxì, and G. Giusti Decrease in HDV endemicity in Italy J Hepatol 26 1997 20 24
4. H. Degertekin, K. Yalcin, and M. Yakut The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies Turk J Gastroenterol 17 2006 25 34
5. G.B. Gaeta, T. Stroffolini, M. Chiaramonte, T. Ascione, G. Stornaiuolo, and S. Lobello Chronic hepatitis D: a vanishing Disease? An Italian multicenter study Hepatology 32 2000 824 827
6. T.J.S. Cross, P. Rizzi, M. Horner, A. Jolly, M.J. Hussain, and H.M. Smith The increasing prevalence of hepatitis delta virus infection in South London J Med Virol 80 2008 277 282
7. H. Wedemeyer, B. Heidrich, and M. Manns Hepatitis D virus infection. Not a vanishing disease in Europe Hepatology 45 2007 1331 1332
8. M. Rizzetto Hepatitis D: the comeback? Liver Int 29 2009 140142
9. P. Marcellin, E. Gane, M. Buti, N. Afdhal, W. Sievert, and I.M. Jacobson Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study Lancet 381 2013 468 475
10. Kasimis C, Kassimi C. Greece: A history of migration. Migration Information Source, 2004. www.migrationinformation.org.
11. Demographics in Greece. Immigration. In: www.en.wikipedia.org/wiki/ Demographics-of-Greece#cite-note-13.
12. Illegal immigration in Greece. The economist, print edition, 8.19.2010. www.economist.com/node/16847278.
13. G.N. Dalekos, E. Zervou, F. Karabini, and E.V. Tsianos Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses Eur J Gastroenterol Hepatol 7 1995 553 558
14. A. Roussos, C. Goritsas, T. Pappas, M. Spanaki, P. Papadaki, and A. Ferti Prevalence of hepatitis B and C markers among refugees in Athens World J Gastroenterol 9 2003 993 995
15. European Association for the Study of the Liver EASL clinical practice guidelines: management of chronic hepatitis B virus infection J Hepatol 57 2012 167 185
16. K. Ishak, A. Baptista, L. Bianchi, E. Callea, J. DeGroote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
17. J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Disease. Management of hepatocellular carcinoma. An update Hepatology 53 2011 1020 1022
18. Boswell C. Migration in Europe. Global Commission on International Migration; 2005. christina.boswell@hwwa.de.
19. J.J. Ott, G.A. Stevens, J. Groeger, and S.T. Wiersma Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2012 2212 2219
20. E.K. Manesis, and A.S. Katsoulidou Hepatitis D virus D. Liu, Molecular detection of human viral pathogens 2011 CRC Press, Taylor & Francis Publishing Co London 1073 1088 [Chapter 30]
21. T. Stroffolini, P.L. Almasio, E. Sagnelli, A. Mele, and G.B. Gaeta Italian Hospitals' Collaborating Group. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study J Med Virol 81 2009 1999 2006
22. A. Erhardt, M. Hoernke, U. Heinzel-Pleines, A. Sagir, T. Göbel, and D. Häussinger Retrospective analysis of chronic hepatitis D in a West German University Clinic over two decades: migratory pattern, prevalence and clinical outcome Z Gastroenterol 48 2010 813 817
23. R. Romeo, E. Del Ninno, M. Rumi, A. Russo, A. Sangiovanni, and R. de Franchis A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma Gastroenterology 136 2009 1629 1638
24. V. Papaevangelou, C. Hadjichristodoulou, D.C. Cassimos, K. Pantelaki, A. Tzivaras, and A. Hatzimichael Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination Infection 36 2008 135 139
25. M. Schaper, F. Rodriguez-Frias, R. Jardi, D. Tabernero, M. Homs, and G. Ruiz Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D J Hepatol 52 2010 658 664
26. H. Wedemeyer, C. YurdaydIn, G.N. Dalekos, A. Erhardt, Y. Cakaloglu, and H. Degertekin For HIDIT Study Group. Peginterferon plus adefovir versus either drug alone for hepatitis delta N Engl J Med 364 2011 322 331
27. C. Triantos, M. Kalafateli, V. Nikolopoulou, and A. Burroughs Meta-analysis: antiviral treatment for hepatitis D Aliment Pharmacol Ther 35 2012 663 673
28. C. Ripoll, R. Groszmann, G. Garcia-Tsao, N. Grace, A. Burroughs, and R. Planas Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis Gastroenterology 133 2007 481 488
29. E.V. Gomez, Y.S. Rodriguez, L.C. Bertot, A.T. Gonzalez, Y.M. Perez, and E.A. Soler The natural history of compensated HCV-related cirrhosis: a prospective long-term study J Hepatol 58 2013 434 444